in caricamento...

Evolution of IL-23 inhibitors for Crohn’s disease management

  • Gastroenterologia
  • webinar

Evento

Evolution of IL-23 inhibitors for Crohn’s disease management

Periodo

22 Mar 2022 - 22 Mar 2022

Speaker

Silvio Danese, Italy - Laurent Peyrin-Biroulet, France - Edouard Louis, Belgium - Sebastian Zeissig, Germany - William Sandborn, California
Scarica il Programma Compila il form di iscrizione

The evolution of biological drugs has made major steps forwards for the treatment of IBD, another mechanism of action is the biologic that inhibit IL-23 and new agents are now coming, new data on new monoclonal antibodies in IL23 are becoming available for the treatment of CD.
The aim of the course is to highlight the recent evolution of IL23 blockers for CD patients.

Compila la richiesta di iscrizione a pagamento a Evolution of IL-23 inhibitors for Crohn’s disease management